FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel cyanoguanidines of the formula (I): or their tautomeric forms where addition to pyridine ring is carried out at 3 or 4 position; R1 means one or more substitutes that can be similar or different and taken among group consisting of hydrogen, halogen atom or C1-C4-alkoxy-group; X means linear or branched, saturated or unsaturated C9-C20-hydrocarbon radical or group Q-Ar-R where Ar means phenyl; Q means linear or branched, saturated or unsaturated C5-C20-bivalent hydrocarbon radical; R means hydrogen or halogen atom. Compounds of the formula (I) inhibit unfavorable cells proliferation and can be used in medicine. EFFECT: improved methods of synthesis, valuable medicinal properties of compounds. 8 cl, 3 tbl, 26 ex
Authors
Dates
2002-12-27—Published
1998-05-15—Filed